Trizivir (Abacavir/Lamivudine/Zidovudine) for HIV

Overview
Trizivir is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications. Trizivir is a combination drug composed of Abacavir, Lamivudine, and Zidovudine, which are also known respectively by the abbreviations ABC, 3TC, and ZDV. Abacavir, Lamivudine, and Zidovudine are all antiviral medications of the nucleoside reverse transcriptase inhibitor (NRTI) class. All three drugs are believed to work by preventing HIV from replicating in cells.

How do I take it?
Prescribing information states that Trizivir is taken twice daily. Trizivir comes in tablet form.

Side effects
The FDA-approved label for Trizivir lists common side effects including headache, fatigue, nausea, malaise, and vomiting. Rare but serious side effects listed for Trizivir include severe hypersensitivity reactions, hematological toxicity (damage to blood cells), myopathy (damage to muscles), lactic acidosis (a metabolic disorder), hepatomegaly (enlarged liver) with steatosis (fatty degeneration), and severe exacerbation of Hepatitis B.

For more details about this treatment, visit:

Trizivir highlights of prescribing information – ViiV Healthcare

Overview of HIV Treatments – AIDS.gov